Schrödinger to Announce First Quarter 2023 Financial Results on May 4

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) is set to release its first quarter 2023 financial results on May 4, 2023, after market close. A conference call will follow at 4:30 p.m. ET. Investors can access the live webcast on the company's website and by phone using conference ID 21402709. Schrödinger employs a physics-based computational platform to expedite the discovery of new therapeutics and materials, significantly reducing time and costs compared to traditional methods. Founded in 1990, the company has around 800 employees and collaborates with clients across more than 70 countries. To explore further, visit www.schrodinger.com.

Positive

• Scheduled financial results release for Q1 2023 indicating ongoing business transparency.
• Utilization of a physics-based platform streamlining drug and materials discovery.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2023 financial results on Thursday, May 4, 2023, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. To access the call by phone, please dial 1-888-396-8049 (domestic) or 1-416-764-8646 (international) and refer to conference ID 21402709. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.

About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has approximately 800 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230420005003/en/

Jaren Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Source: Schrödinger

FAQ

When will Schrödinger report its first quarter 2023 financial results?

Schrödinger will report its first quarter 2023 financial results on May 4, 2023, after the market closes.

What time is the conference call for Schrödinger's Q1 2023 results?

The conference call for Schrödinger's Q1 2023 results will take place at 4:30 p.m. ET.

How can I access Schrödinger's Q1 2023 results call?

You can access Schrödinger's Q1 2023 results call via a live webcast on their website or by phone using conference ID 21402709.

What is Schrödinger's business focus?

Schrödinger focuses on transforming drug and materials discovery using a physics-based computational platform.

How many employees does Schrödinger have?

Schrödinger has approximately 800 employees.